Efficacy and Safety of Ulotaront in the Treatment of Schizophrenia: Results of Two 6-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials

被引：0

作者：

Kane, John ^{[1
]}

Dworak, Heather ^{[1
]}

Koblan, Kenneth ^{[1
]}

Szegedi, Armin ^{[1
]}

Goldman, Robert ^{[1
]}

Li, Yan ^{[1
]}

Fitzgerald, Alison ^{[1
]}

Loebel, Antony ^{[1
]}

Marder, Stephen ^{[1
]}

机构：

[1] Sunovion Pharmaceut Inc, Teaneck, NJ USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷

关键词：

Schizophrenia (SCZ); TAAR1; Phase III Trial; Clinical Trial; Ulotaront;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

P495

引用

页码：351 / 351

页数：1

共 50 条

[1] Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study
Iyo, Masaomi
Ishigooka, Jun
Nakamura, Masatoshi
Sakaguchi, Reiko
Okamoto, Keisuke
Mao, Yongcai
Tsai, Joyce
Fitzgerald, Alison
Nosaka, Tadashi
Higuchi, Teruhiko
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, : 227 - 235
[2] Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study
Iyo, Masaomi
Ishigooka, Jun
Nakamura, Masatoshi
Sakaguchi, Reiko
Okamoto, Keisuke
Mao, Yongcai
Tsai, Joyce
Fitzgerald, Alison
Nosaka, Tadashi
Higuchi, Teruhiko
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (07) : 227 - 235
[3] A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia
Shen, Joan H. Q.
Zhao, Yonggang
Rosenzweig-Lipson, Sharon
Popp, Danielle
Williams, Janet B. W.
Giller, Earl
Detke, Michael J.
Kane, John M.
JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 53 : 14 - 22
[4] Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials
Grossberg, George T.
Kohegyi, Eva
Mergel, Victor
Josiassen, Mette Krog
Meulien, Didier
Hobart, Mary
Slomkowski, Mary
Baker, Ross A.
McQuade, Robert D.
Cummings, Jeffrey L.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04) : 383 - 400
[5] Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
Masaaki Ogasa
Tatsuya Kimura
Mitsutaka Nakamura
John Guarino
Psychopharmacology, 2013, 225 : 519 - 530
[6] Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
Ogasa, Masaaki
Kimura, Tatsuya
Nakamura, Mitsutaka
Guarino, John
PSYCHOPHARMACOLOGY, 2013, 225 (03) : 519 - 530
[7] A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults
He, Shen
Yu, Yimin
Huang, Jingjing
Yin, Jiahui
Niu, Yajuan
Lu, Yazhou
Wu, Bin
Fang, Maosheng
Wang, Xue
Tao, Zhiping
Li, Lehua
Li, Kan
Li, Yan
Ding, Xiujuan
Shen, Yifeng
Li, Huafang
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2023, 13
[8] Predictors of Response to Ziprasidone: Results from a 6-Week Randomized Double-Blind, Placebo-Controlled Trial for Acute Depressive Mixed State
Pae, C. -U.
Patkar, A. A.
Gilmer, W.
Holtzman, N.
Thommi, S. B.
Ghaemi, S. N.
PHARMACOPSYCHIATRY, 2012, 45 (04) : 152 - 155
[9] Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
Silberstein, Stephen D.
Lipton, Richard B.
Dodick, David W.
Freitag, Frederick G.
Ramadan, Nabih
Mathew, Ninan
Brandes, Jan L.
Bigal, Marcelo
Saper, Joel
Ascher, Steven
Jordan, Donna M.
Greenberg, Steven J.
Hulihan, Joseph
HEADACHE, 2007, 47 (02): : 170 - 180
[10] Efficacy of melatonin in the treatment of endometriosis: A phase II, randomized, double-blind, placebo-controlled trial
Schwertner, Andre
Conceicao dos Santos, Claudia C.
Costa, Gislene Dalferth
Deitos, Alicia
de Souza, Andressa
Custodio de Souza, Izabel Cristina
Torres, Iraci L. S.
da Cunha Filho, Joao Sabino L.
Caumo, Wolnei
PAIN, 2013, 154 (06) : 874 - 881

← 1 2 3 4 5 →